Reviews Anti-Inhibitor Coagulant Complex, Vapor Heated


No reviews yet.

Feiba Vh Drug Description
FEIBA VH
Anti-Inhibitor Coagulant Complex
Vapor Heated
DRUG DESCRIPTION



What are the possible side effects of anti-inhibitor coagulant complex (Autoplex T, Feiba VH)?

Anti-inhibitor coagulant complex is made from human plasma (part of the blood) and may contain infectious agents (e.g., viruses) that can cause disease. Although anti-inhibitor coagulant complex is screened, tested, and treated to reduce the possibility that it carries an infectious agent, it can still potentially transmit disease. Discuss with your doctor the risks and benefits of using anti-inhibitor coagulant complex.
Some viruses, such as parovovirus B19 and hepatitis A,...
Read All Potential Side Effects for Feiba Vh »




FEIBA VH Anti-Inhibitor Coagulant Complex, Vapor Heated (AICC) is a
freeze-dried sterile human plasma fraction with Factor VIII inhibitor bypassing
activity. In vitro, FEIBA VH (AICC) shortens the activated partial thromboplastin
time (APTT) of plasma containing Factor VIII inhibitor. Factor VIII inhibitor
bypassing activity is expressed in arbitrary units. One IMMUNO Unit of activity
is defined as that amount of FEIBA VH (AICC) that shortens the APTT of a high
titer Factor VIII inhibitor reference plasma to 50% of the blank value. The
product is intended for intravenous administration.
FEIBA VH (AICC) contains Factors II, IX, and X, mainly non-activated,
and Factor VII1┬ľ3 mainly in the activated form. The product contains
approximately equal unitages of Factor VIII inhibitor bypassing activity and
Prothrombin Complex Factors. In addition, 1 ┬ľ 6 units of Factor VIII coagulant
antigen (FVIII C:Ag) per mL are present. The preparation contains only traces
of factors of the kinin generating system. It contains no heparin.
Reconstituted FEIBA VH (AICC) contains 4 mg of trisodium citrate and 8 mg of sodium chloride per mL.
FEIBA VH (AICC), Vapor Heated has been prepared from Source Plasma and/or Plasma.
The product has been subjected to in-process virus inactivation where vapor
is first applied for 10 hours at 60° ┬▒ 0.5°C and an excess pressure
of 190 ┬▒ 20 mbar followed by 1 hour at 80°┬▒ 0.5°C and an excess pressure
of 370 ┬▒ 30 mbar. (See CLINICAL PHARMACOLOGY
and WARNINGS sections).
REFERENCES
1. Elsinger F.: Aktivierter Faktor VII in Prothrombinkomplex-Konzentraten.
23rd Annual Meeting of ┬äDeutsche Arbeitsgemeinschaft für Blutgerinnungsforschung"
(DAB), Heidelberg, 1979. F. K. Schattauer Verlag, Stuttgart-New York, 367, 1980.
2. Seligsohn U., Østerud B., Rapaport S. I.: Coupled Amidolytic Assay
for Factor VII: Its Use With a Clotting Assay to Determine the Activity State
of Factor VII. Blood 52: 978, 1978.
3. Seligsohn U., Kasper C. K., Østerud B., Rapaport S. I.: Activated
Factor VII: Presence in Factor IX Concentrates and Persistence in the Circulation
After Infusion. Blood 53: 828, 1979.Last reviewed on RxList: 10/7/2008




Feiba Vh Drug Description
FEIBA VH
Anti-Inhibitor Coagulant Complex
Vapor Heated
DRUG DESCRIPTION



What are the possible side effects of anti-inhibitor coagulant complex (Autoplex T, Feiba VH)?

Anti-inhibitor coagulant complex is made from human plasma (part of the blood) and may contain infectious agents (e.g., viruses) that can cause disease. Although anti-inhibitor coagulant complex is screened, tested, and treated to reduce the possibility that it carries an infectious agent, it can still potentially transmit disease. Discuss with your doctor the risks and benefits of using anti-inhibitor coagulant complex.
Some viruses, such as parovovirus B19 and hepatitis A,...
Read All Potential Side Effects for Feiba Vh »




FEIBA VH Anti-Inhibitor Coagulant Complex, Vapor Heated (AICC) is a
freeze-dried sterile human plasma fraction with Factor VIII inhibitor bypassing
activity. In vitro, FEIBA VH (AICC) shortens the activated partial thromboplastin
time (APTT) of plasma containing Factor VIII inhibitor. Factor VIII inhibitor
bypassing activity is expressed in arbitrary units. One IMMUNO Unit of activity
is defined as that amount of FEIBA VH (AICC) that shortens the APTT of a high
titer Factor VIII inhibitor reference plasma to 50% of the blank value. The
product is intended for intravenous administration.
FEIBA VH (AICC) contains Factors II, IX, and X, mainly non-activated,
and Factor VII1┬ľ3 mainly in the activated form. The product contains
approximately equal unitages of Factor VIII inhibitor bypassing activity and
Prothrombin Complex Factors. In addition, 1 ┬ľ 6 units of Factor VIII coagulant
antigen (FVIII C:Ag) per mL are present. The preparation contains only traces
of factors of the kinin generating system. It contains no heparin.
Reconstituted FEIBA VH (AICC) contains 4 mg of trisodium citrate and 8 mg of sodium chloride per mL.
FEIBA VH (AICC), Vapor Heated has been prepared from Source Plasma and/or Plasma.
The product has been subjected to in-process virus inactivation where vapor
is first applied for 10 hours at 60° ┬▒ 0.5°C and an excess pressure
of 190 ┬▒ 20 mbar followed by 1 hour at 80°┬▒ 0.5°C and an excess pressure
of 370 ┬▒ 30 mbar. (See CLINICAL PHARMACOLOGY
and WARNINGS sections).
REFERENCES
1. Elsinger F.: Aktivierter Faktor VII in Prothrombinkomplex-Konzentraten.
23rd Annual Meeting of ┬äDeutsche Arbeitsgemeinschaft für Blutgerinnungsforschung"
(DAB), Heidelberg, 1979. F. K. Schattauer Verlag, Stuttgart-New York, 367, 1980.
2. Seligsohn U., Østerud B., Rapaport S. I.: Coupled Amidolytic Assay
for Factor VII: Its Use With a Clotting Assay to Determine the Activity State
of Factor VII. Blood 52: 978, 1978.
3. Seligsohn U., Kasper C. K., Østerud B., Rapaport S. I.: Activated
Factor VII: Presence in Factor IX Concentrates and Persistence in the Circulation
After Infusion. Blood 53: 828, 1979.Last reviewed on RxList: 10/7/2008




Feiba Vh Drug Description
FEIBA VH
Anti-Inhibitor Coagulant Complex
Vapor Heated
DRUG DESCRIPTION



What are the possible side effects of anti-inhibitor coagulant complex (Autoplex T, Feiba VH)?

Anti-inhibitor coagulant complex is made from human plasma (part of the blood) and may contain infectious agents (e.g., viruses) that can cause disease. Although anti-inhibitor coagulant complex is screened, tested, and treated to reduce the possibility that it carries an infectious agent, it can still potentially transmit disease. Discuss with your doctor the risks and benefits of using anti-inhibitor coagulant complex.
Some viruses, such as parovovirus B19 and hepatitis A,...
Read All Potential Side Effects for Feiba Vh »




FEIBA VH Anti-Inhibitor Coagulant Complex, Vapor Heated (AICC) is a
freeze-dried sterile human plasma fraction with Factor VIII inhibitor bypassing
activity. In vitro, FEIBA VH (AICC) shortens the activated partial thromboplastin
time (APTT) of plasma containing Factor VIII inhibitor. Factor VIII inhibitor
bypassing activity is expressed in arbitrary units. One IMMUNO Unit of activity
is defined as that amount of FEIBA VH (AICC) that shortens the APTT of a high
titer Factor VIII inhibitor reference plasma to 50% of the blank value. The
product is intended for intravenous administration.
FEIBA VH (AICC) contains Factors II, IX, and X, mainly non-activated,
and Factor VII1┬ľ3 mainly in the activated form. The product contains
approximately equal unitages of Factor VIII inhibitor bypassing activity and
Prothrombin Complex Factors. In addition, 1 ┬ľ 6 units of Factor VIII coagulant
antigen (FVIII C:Ag) per mL are present. The preparation contains only traces
of factors of the kinin generating system. It contains no heparin.
Reconstituted FEIBA VH (AICC) contains 4 mg of trisodium citrate and 8 mg of sodium chloride per mL.
FEIBA VH (AICC), Vapor Heated has been prepared from Source Plasma and/or Plasma.
The product has been subjected to in-process virus inactivation where vapor
is first applied for 10 hours at 60° ┬▒ 0.5°C and an excess pressure
of 190 ┬▒ 20 mbar followed by 1 hour at 80°┬▒ 0.5°C and an excess pressure
of 370 ┬▒ 30 mbar. (See CLINICAL PHARMACOLOGY
and WARNINGS sections).
REFERENCES
1. Elsinger F.: Aktivierter Faktor VII in Prothrombinkomplex-Konzentraten.
23rd Annual Meeting of ┬äDeutsche Arbeitsgemeinschaft für Blutgerinnungsforschung"
(DAB), Heidelberg, 1979. F. K. Schattauer Verlag, Stuttgart-New York, 367, 1980.
2. Seligsohn U., Østerud B., Rapaport S. I.: Coupled Amidolytic Assay
for Factor VII: Its Use With a Clotting Assay to Determine the Activity State
of Factor VII. Blood 52: 978, 1978.
3. Seligsohn U., Kasper C. K., Østerud B., Rapaport S. I.: Activated
Factor VII: Presence in Factor IX Concentrates and Persistence in the Circulation
After Infusion. Blood 53: 828, 1979.Last reviewed on RxList: 10/7/2008




Feiba Vh Drug Description
FEIBA VH
Anti-Inhibitor Coagulant Complex
Vapor Heated
DRUG DESCRIPTION



What are the possible side effects of anti-inhibitor coagulant complex (Autoplex T, Feiba VH)?

Anti-inhibitor coagulant complex is made from human plasma (part of the blood) and may contain infectious agents (e.g., viruses) that can cause disease. Although anti-inhibitor coagulant complex is screened, tested, and treated to reduce the possibility that it carries an infectious agent, it can still potentially transmit disease. Discuss with your doctor the risks and benefits of using anti-inhibitor coagulant complex.
Some viruses, such as parovovirus B19 and hepatitis A,...
Read All Potential Side Effects for Feiba Vh »




FEIBA VH Anti-Inhibitor Coagulant Complex, Vapor Heated (AICC) is a
freeze-dried sterile human plasma fraction with Factor VIII inhibitor bypassing
activity. In vitro, FEIBA VH (AICC) shortens the activated partial thromboplastin
time (APTT) of plasma containing Factor VIII inhibitor. Factor VIII inhibitor
bypassing activity is expressed in arbitrary units. One IMMUNO Unit of activity
is defined as that amount of FEIBA VH (AICC) that shortens the APTT of a high
titer Factor VIII inhibitor reference plasma to 50% of the blank value. The
product is intended for intravenous administration.
FEIBA VH (AICC) contains Factors II, IX, and X, mainly non-activated,
and Factor VII1┬ľ3 mainly in the activated form. The product contains
approximately equal unitages of Factor VIII inhibitor bypassing activity and
Prothrombin Complex Factors. In addition, 1 ┬ľ 6 units of Factor VIII coagulant
antigen (FVIII C:Ag) per mL are present. The preparation contains only traces
of factors of the kinin generating system. It contains no heparin.
Reconstituted FEIBA VH (AICC) contains 4 mg of trisodium citrate and 8 mg of sodium chloride per mL.
FEIBA VH (AICC), Vapor Heated has been prepared from Source Plasma and/or Plasma.
The product has been subjected to in-process virus inactivation where vapor
is first applied for 10 hours at 60° ┬▒ 0.5°C and an excess pressure
of 190 ┬▒ 20 mbar followed by 1 hour at 80°┬▒ 0.5°C and an excess pressure
of 370 ┬▒ 30 mbar. (See CLINICAL PHARMACOLOGY
and WARNINGS sections).
REFERENCES
1. Elsinger F.: Aktivierter Faktor VII in Prothrombinkomplex-Konzentraten.
23rd Annual Meeting of ┬äDeutsche Arbeitsgemeinschaft für Blutgerinnungsforschung"
(DAB), Heidelberg, 1979. F. K. Schattauer Verlag, Stuttgart-New York, 367, 1980.
2. Seligsohn U., Østerud B., Rapaport S. I.: Coupled Amidolytic Assay
for Factor VII: Its Use With a Clotting Assay to Determine the Activity State
of Factor VII. Blood 52: 978, 1978.
3. Seligsohn U., Kasper C. K., Østerud B., Rapaport S. I.: Activated
Factor VII: Presence in Factor IX Concentrates and Persistence in the Circulation
After Infusion. Blood 53: 828, 1979.Last reviewed on RxList: 10/7/2008




Feiba Vh Drug Description
FEIBA VH
Anti-Inhibitor Coagulant Complex
Vapor Heated
DRUG DESCRIPTION



What are the possible side effects of anti-inhibitor coagulant complex (Autoplex T, Feiba VH)?

Anti-inhibitor coagulant complex is made from human plasma (part of the blood) and may contain infectious agents (e.g., viruses) that can cause disease. Although anti-inhibitor coagulant complex is screened, tested, and treated to reduce the possibility that it carries an infectious agent, it can still potentially transmit disease. Discuss with your doctor the risks and benefits of using anti-inhibitor coagulant complex.
Some viruses, such as parovovirus B19 and hepatitis A,...
Read All Potential Side Effects for Feiba Vh »




FEIBA VH Anti-Inhibitor Coagulant Complex, Vapor Heated (AICC) is a
freeze-dried sterile human plasma fraction with Factor VIII inhibitor bypassing
activity. In vitro, FEIBA VH (AICC) shortens the activated partial thromboplastin
time (APTT) of plasma containing Factor VIII inhibitor. Factor VIII inhibitor
bypassing activity is expressed in arbitrary units. One IMMUNO Unit of activity
is defined as that amount of FEIBA VH (AICC) that shortens the APTT of a high
titer Factor VIII inhibitor reference plasma to 50% of the blank value. The
product is intended for intravenous administration.
FEIBA VH (AICC) contains Factors II, IX, and X, mainly non-activated,
and Factor VII1┬ľ3 mainly in the activated form. The product contains
approximately equal unitages of Factor VIII inhibitor bypassing activity and
Prothrombin Complex Factors. In addition, 1 ┬ľ 6 units of Factor VIII coagulant
antigen (FVIII C:Ag) per mL are present. The preparation contains only traces
of factors of the kinin generating system. It contains no heparin.
Reconstituted FEIBA VH (AICC) contains 4 mg of trisodium citrate and 8 mg of sodium chloride per mL.
FEIBA VH (AICC), Vapor Heated has been prepared from Source Plasma and/or Plasma.
The product has been subjected to in-process virus inactivation where vapor
is first applied for 10 hours at 60° ┬▒ 0.5°C and an excess pressure
of 190 ┬▒ 20 mbar followed by 1 hour at 80°┬▒ 0.5°C and an excess pressure
of 370 ┬▒ 30 mbar. (See CLINICAL PHARMACOLOGY
and WARNINGS sections).
REFERENCES
1. Elsinger F.: Aktivierter Faktor VII in Prothrombinkomplex-Konzentraten.
23rd Annual Meeting of ┬äDeutsche Arbeitsgemeinschaft für Blutgerinnungsforschung"
(DAB), Heidelberg, 1979. F. K. Schattauer Verlag, Stuttgart-New York, 367, 1980.
2. Seligsohn U., Østerud B., Rapaport S. I.: Coupled Amidolytic Assay
for Factor VII: Its Use With a Clotting Assay to Determine the Activity State
of Factor VII. Blood 52: 978, 1978.
3. Seligsohn U., Kasper C. K., Østerud B., Rapaport S. I.: Activated
Factor VII: Presence in Factor IX Concentrates and Persistence in the Circulation
After Infusion. Blood 53: 828, 1979.Last reviewed on RxList: 10/7/2008





Other reviews about Anti-Inhibitor Coagulant Complex, Vapor Heated on web:

Resources for You. Untitled Letters Regarding Advertising & Promotional Labeling for Approved Biologics -- Anti-Inhibitor Coagulant Complex, Vapor Heated (FEIBA VH)


C IGNA M EDICAL C OVERAGE P OLICY The following Coverage Policy applies to all plans administered by CIGNA Companies including plans administered by Great-West Healthcare, which is now a ... anti-inhibitor coagulant complex vapor heated (Feiba VH)


Learn about the prescription medication Feiba Vh (Anti-Inhibitor Coagulant Complex, Vapor Heated), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient ... Feiba Vh (Anti-Inhibitor Coagulant Complex, Vapor Heated) Drug ...


FEIBA VH Anti-Inhibitor Coagulant Complex, Vapor Heated 651-1200 Activity Units 922204 Baxter US Product Catalog - FEIBA VH Anti-Inhibitor Coagulant ...


FEIBA VH Anti-Inhibitor Coagulant Complex, Vapor Heated 1750-3250 Activity Units 1500696 Baxter US Product Catalog - FEIBA VH Anti-Inhibitor Coagulant ...


BAXTER Anti-Inhibitor Coagulant Complex Feiba VH Vapor Heated DESCRIPTION Anti-Inhibitor Coagulant Complex, Feiba VH, Vapor Heated, is a freeze-dried sterile human plasma fraction ... BAXTER Anti-Inhibitor Coagulant Complex Feiba VH Vapor Heated ...


Page 1 FEIBA NF (Anti-Inhibitor Coagulant Complex), Nanofiltered and Vapor Heated Lyophilized powder for solution Intravenous WARNING Thrombotic and thromboembolic events have been ... FEIBA NF (Anti-Inhibitor Coagulant Complex), Nanofiltered and ...


FEIBA VH SUMMARY FEIBA VH Anti-Inhibitor Coagulant Complex, Vapor Heated (AICC) is a freeze-dried sterile human plasma fraction with Factor VIII inhibitor bypassing activity. Feiba VH (Anti-Inhibitor Coagulant Complex) - Drug Info, Side ...


Hilgartner M, Aledort L, Andes A, et al. Efficacy and safety of vapor-heated anti-inhibitor coagulant complex in hemophilia patients. Transfusion 1990; 30: 626-30. Activated prothrombin complex concentrate Drug Information ...


FEIBA NF (Anti-Inhibitor Coagulant Complex), nanofiltered and vapor heated, is a freeze-dried sterile human plasma fraction with Factor VIII inhibitor bypassing activity. FEIBA NF Official FDA information, side effects and uses.





Featured Reviews

Reviews Onsolis

Onsolis Drug Description Onsolis (fentanyl buccal soluble film) WARNINGS IMPORTANCE OF PROPER PATIENT SELECTION AND POTENTIAL FOR ABUSE Onsolis contains fentanyl, an opioid agonist and a Schedule II controlled substance, with...
Read More  |  Review This
Reviews Pegaspargase

Oncaspar Drug Description Oncaspar® (pegaspargase) Intravenous -or- Intramuscular Injection DRUG DESCRIPTION What are the possible side effects of pegaspargase (Oncaspar)? Get emergency medical help if you have any of these...
Read More  |  Review This
Reviews Sodium Sulfacetamide 10% and Sulfur 5% lotion

Sodium Sulfacetamide 10% and Sulfur 5% lotion Drug Description Sodium Sulfacetamide 10% and Sulfur 5% lotion (Tint Free) DRUG DESCRIPTION Each mL of Sodium Sulfacetamide 10% and Sulfur 5% Lotion (Tint Free) as dispensed contains 100 mg...
Read More  |  Review This
Reviews Mometasone Furoate Ointment

Elocon Ointment Drug Description ELOCON® (mometasone furoate) Ointment 0.1%
For Dermatologic Use Only Not for Ophthalmic Use DRUG DESCRIPTION What are the possible side effects of mometasone topical (Elocon)? Get emergency...

Read More  |  Review This
Reviews Mesalamine Delayed-Release Tablets

Asacol Drug Description Asacol® (mesalamine) Delayed-Release Tablets DRUG DESCRIPTION What are the possible side effects of mesalamine oral (Apriso, Asacol, Lialda, Pentasa)? Get emergency medical help if you have any...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....